Author pages are created from data sourced from our academic publisher partnerships and public sources.
Share This Author
Clinicopathologic features and prognosis of combined hepatocellular cholangiocarcinoma.
BACKGROUND Clinicopathologic features and prognosis of combined hepatocellular cholangiocarcinoma (HCC-CC) have not been established. METHODS Data of patients who underwent surgical resection for… Expand
Comparing the Outcomes of Radiofrequency Ablation and Surgery in Patients With a Single Small Hepatocellular Carcinoma and Well-Preserved Hepatic Function
- S. N. Hong, Sun-Young Lee, +9 authors J. Joh
- Journal of clinical gastroenterology
- 1 March 2005
Goals: To compare the efficacy of radiofrequency ablation (RFA) and surgical resection in a group of patients with a Child-Pugh score of 5 and a single HCC less than 4 cm in diameter. Background:… Expand
Balloon-occluded retrograde transvenous obliteration of gastric varices: outcomes and complications in 49 patients.
OBJECTIVE Our aim was to evaluate the clinical outcomes, techniques, and complications of balloon-occluded retrograde transvenous obliteration for treating gastric varices with spontaneous… Expand
Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma: analysis of prognostic factors.
BACKGROUND & AIMS The aim was to assess 10-year outcomes of radiofrequency ablation as a first-line therapy of early-stage hepatocellular carcinoma with an analysis of prognostic factors. METHODS… Expand
Three‐dimensional conformal radiotherapy for portal vein thrombosis of hepatocellular carcinoma
Portal vein thrombosis (PVT) is a common complication in patients with advanced‐stage hepatocellular carcinoma (HCC). The authors evaluated the impact of radiotherapy (RT) for PVT of HCC and analyzed… Expand
Local radiotherapy for patients with unresectable hepatocellular carcinoma.
- W. Park, D. Lim, +10 authors S. Huh
- International journal of radiation oncology…
- 15 March 2005
PURPOSE To evaluate the response to local radiotherapy (RT) for unresectable hepatocellular carcinoma (HCC) and to analyze the dose-response relationship and the treatment-related morbidities. … Expand
Liver abscess after percutaneous radiofrequency ablation for hepatocellular carcinomas: frequency and risk factors.
OBJECTIVE The purpose of this study was to clarify the frequency and risk factors of liver abscess formation after percutaneous radiofrequency ablation in patients with hepatocellular carcinoma. … Expand
Percutaneous Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma After Hepatectomy: Long-term Results and Prognostic Factors
BackgroundWe evaluated the long-term survival results and safety of percutaneous radiofrequency ablation (RFA) for recurrent hepatocellular carcinoma (HCC) after hepatectomy, and assessed the… Expand
Combined Hepatectomy and Radiofrequency Ablation for Multifocal Hepatocellular Carcinomas: Long-term Follow-up Results and Prognostic Factors
BackgroundFor multifocal hepatocellular carcinomas (HCCs) that are untreatable with resection only, locoregional therapies added to hepatectomy have been introduced. However, some preliminary reports… Expand
Patients with chronic hepatitis B treated with oral antiviral therapy retain a higher risk for HCC compared with patients with inactive stage disease
Background It is generally stated that oral antiviral therapy in patients with chronic hepatitis B (CHB) decreases the risk of developing hepatocellular carcinoma (HCC). Although oral nucleos(t)ide… Expand